Galectin Therapeutics Inc. (GALT)

[thefamilyman]

So much for having the FDA's "Fast Track" designation...

I wonder how the new focus on expanding compassionate use might come into play. GR-MD-02 has successfully completed Phase 1 trials. If I was dying because I could not get a liver transplant, I would be doing everything in my power to get treated with GR-MD-02.

I had the same question but found the answer in the updated presentation on their website. Last enrollment isn't expected until July 2016 even though the first group is July 2015, which then lasts a year, and then a few months to compile the data brings us to q417. Having to wait almost three years wasn't expected (at least by me) which is probably why the stock price is sinking again. I was really hoping we'd have some results reported by the end of the year. - jmh0602